Literature DB >> 606796

Effect of priming infection on serologic response to whole and subunit influenza virus vaccines in animals.

C McLaren, M W Verbonitz, S Daniel, G E Grubbs, F A Ennis.   

Abstract

Results from studies in humans demonstrated that the serologic responses to A/New Jersey (NJ)/76 virus vaccines varied according to the age of the vaccine and appeared to be related to previous exposure of vaccinees to the different strains and influenza A virus. Experiments in animals were therefore performed to investigate the role of previous infection on responses to A/NJ/76 virus vaccines. Mice were infected with influenza A viruses representative of the major strains (Hsw1N1, H0N1, H2N2, H3N2) and later inoculated with various doses of whole or subunit A/NJ/76 virus vaccines. Results from experiments in mice demonstrated a low antigenicity of the subunit vaccine in unprimed animals compared with that of whole-virus vaccine; however, the antigenicity of both vaccines was enhanced in mice primed by previous infection with H0 and H1 viruses. In hamsters previously infected with an H3N2 virus, however, the response to only the whole-virus vaccine was enhanced by the priming infection. The responses of the mice were qualitatively more similar to those of humans than were the responses of hamsters.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606796     DOI: 10.1093/infdis/136.supplement_3.s706

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

2.  Relative antigenicity in mice of H1N1, H3N2 and B strains present in inactivated influenza virus vaccines.

Authors:  M L Profeta; M Ruggeri
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

3.  Responses of volunteers to inactivated influenza virus vaccines.

Authors:  R Jennings; C W Potter; P M Massey; B I Duerden; J Martin; A M Bevan
Journal:  J Hyg (Lond)       Date:  1981-02

Review 4.  Aging affects human B cell responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  J Clin Immunol       Date:  2011-02-12       Impact factor: 8.317

5.  Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.

Authors:  James D Allen; Ted M Ross
Journal:  J Virol       Date:  2022-03-15       Impact factor: 6.549

6.  Immunoglobulin M and G antibody response to type- and subtype-specific antigens after primary and secondary exposures of mice to influenza A viruses.

Authors:  N J Gonchoroff; A P Kendal; D J Phillips; C B Reimer
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

Review 7.  Vaccination against virus diseases.

Authors:  K R Schell
Journal:  Soz Praventivmed       Date:  1979-10

8.  Comparative antigenicity and immunogenicity of A/USSR/77 influenza vaccines in normal and primed mice.

Authors:  C McLaren; G E Grubbs; E Staton; W Barthlow; G Quinnan; F A Ennis
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Authors:  Felix Geeraedts; Nadege Goutagny; Veit Hornung; Martina Severa; Aalzen de Haan; Judith Pool; Jan Wilschut; Katherine A Fitzgerald; Anke Huckriede
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.